Lupus is a relatively rare inflammatory disease. In the US 1.5 million are currently living with the condition. It is an autoimmune disease that can affect various organs including the skin, joints, kidneys, and brain.
What are the causes of this disease?
Lupus is caused by the immune system, when it mistakenly attacks the organs in the body as if they were pathogens such as bacteria and viruses. This autoimmune disease causes a person’s body to mistakenly attack healthy tissue.
The causes of lupus disease are not yet known, but some studies suggest that external factors play a role in the development of the disease, such as genetic predisposition and the use of certain medications. For example, lupus can be triggered by exposure to ultraviolet light, drug allergies, viruses, or even strong emotions.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.
